Since Apeiron Biologics was founded in 2003, it has participated in 2 rounds of funding. In total Apeiron Biologics has raised $49.4M. Apeiron Biologics' last funding round was on Jun 2020 for a total of $19.5M.
Apeiron Biologics has 6 investors, including Vienna Insurance Group, Austrian Research Promotion Agency and Vienna Business Agency. The latest investment occurred in Jun 2020.